Skip to main content

Russell Investments Group, Ltd.

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1692234 Seattle, WA

Position in XERS

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$2,228,328
-$635,235 QoQ
Shares Held
384,195
+5.3% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 89.65317091581099.ToString("F0")% Shared 0.ToString("F0")% None 10.346829084189018.ToString("F0")%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. XERS ranks #20 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,228,328 384,195
2025-12-31 $2,863,563 364,786
2025-09-30 $2,046,213 251,378
2025-06-30 $575,290 123,189
2025-03-31 $722,959 131,687
2024-12-31 $60,931 17,974
2024-09-30 $3,209 1,126
2024-06-30 $893 397
2024-03-31 $446 202
2023-09-30 $221 119